Psych drugs Flashcards
Haloperidol
Typical antipsychotic - block D2 receptors
-Treat schiozphrenia, psychosis, bipolar, delirium, etc.
High potency –> EPS
pimozide
Typical antipsychotic - block D2 receptors
Trifluoperazine
Typical antipsychotic - block D2 receptors
-High potentcy –> EPS
Fluphenazine
Typical antipsychotic - block D2 receptors
- High potentcy –> EPS
- tourette syndrome
Thioridazine
Typical antipsychotic - block D2 receptors
-low potency so more anticholinergic, antihistamine, and alpha 1 blockade effects
Chlorpromazine
Typical antipsychotic - block D2 receptors
-low potency so more anticholinergic, antihistamine, and alpha 1 blockade effects
Atypical antipsychotics uses
schizophrenia, psychosis, bipolar, delirium, tourette syndrome, huntington disease, OCD
Atypical antipsychotics adverse effects
EPS - ADAPT (acute dystonia, akathsia, parkinsonism, Tardive dyskinesia
NMS - neuroleptic malignant syndrome
Endocrine: galactorrhea, oligomenorrhea, gynecomastia
Metabolic: dyslipidemia, weight gain, hyperglycemia
Antimuscarinic: dry mouth, constipation, urinary retention
Antihistamine: sedation
Alpha 1 block: orthostatic hypotension
Neuroleptic malignant syndrome: presentation and treatment
cause= typical anti-psychotics
Presentation: muscle rigidity, diaphoresis, hyperpyrexia, ANS instability, SEVERE (10% fatal)
Treat: dantrolene (muscle relaxor) + bromocriptine (DA agonist)
Aripiprazole
Atypical antipsychotic
-Partial D2 agonist
reduce positive and negative symtpoms
Asenapine
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
Adverse effects: metabolic syndrome (pines)
Clozapine
Atypical antipsychotic
- D2 antagonist, effects on 5HT2, H1, alpha
- used for treatment resistant schizophrenia or schizoaffective d/o and suicidality in schizophrenia
- Adverse effects: agranulocytosis (must monitor WBCs), and seizures (dose related), obesity
Olanzapine
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
Adverse effects: metabolic syndrome (pines), obesity
Quetiapine
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
Adverse effects: metabolic syndrome (pines)
Iloperidone
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
paliperidone
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
risperidone
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
Adverse affects: hyperprolactinemia (amenorrhea, galactorrhea, gynecomastia)
-tourette syndrome
Lurasidone
Atypical antipsychotic
-D2 antagonist, effects on 5HT2, H1, alpha
Atypical antipsychotic clinical uses
Schizophrenia (+/- symtpoms)
Bipolar Disorder, OCD, anxiety disorder, depression, maina, tourette syndrome
Atypical antispychotic adverse effect profile
prolonged QT interval, fewer EPS and anticholinergic effects compared to typicals
Pines: metbaolic syndrome
clozapine: agranulocytosis, seizures
Risperidone: hyperprolactinemia
Benzodiazepines mechanism of action
facilitate GABAa action by increasing frequency of CL- channel opening. leads to increased GABAergic inhibition
Clinical uses of benzodiazepines
Anxiety, spasticity, status epilepticus, insomnia, muscle relaxant, sedation for minor procedures, eclampsia, delirum tremens/alcohol withdrawal trt., night terrors, sleep walking,
Benzodiazepine adverse effects
dependence, CNS depression with alcohol
Flumazenil
Competitive Antagonist of GABA-R
antagonizes BZs and ZZZ drugs
Treats benzo overdose
Can precipitate seizure froma cute benzo withdrawal
Oxazepam
Short acting benzodiazepine (higher addiction potential)
Can be used to treat alcohol withdrawal in patients with liver disease because minimal first pass metabolism
Midazolam
Short acting benzodiazepine (higher addiction potential)
Alprazolam
Short acting benzodiazepine (higher addiction potential)
Triazolam
Short acting benzodiazepine (higher addiction potential)
Temazepam
Benzodiazepine
Can be used to treat alcohol withdrawal in patients with liver disease because minimal first pass metabolism
Lorazepam
Benzodiazepine
Can be used to treat alcohol withdrawal in patients with liver disease because minimal first pass metabolism
Zolpidem
Zaleplon
eszopiclone (mechanism, use, adverse effects)
Act via BZ1 GABA receptor subtype. used to treat
Use: insomnia
Adverse effects: ataxia, headaches, confusion. rebound insomnia at high doses (zol+zal) . few amnestic effects and lower risk of dependency than benzos.
short acting because rapid metabolism by liver enzymes
Ramelton
Tasimelton
(mechanism, use, adverse effects)
melatonin receptor agonists (binds MT1 and MT2 in suprachiasmatic)
Clinical use: insomnia
Adverse effects: dizziness, nausea, fatigue, headache
No dependence
Suvorexant
mechanism, use, adverse effects
Orexin receptor antagonist (OX1, OX2) - orexin involved in wake pathway
“Sleep driving”, amnestic effects
solmolence, headache, dizziness, abnormal dreams, URTI
contraindications: narcolepsy, strong CYP3A4 inhibitors
Buspirone
Partial 5-HT agonist
2nd line for GAD
Adverse effects: Nausea, abdominal pain, drowsiness, dizziness
Inconsistent long term efficacy
takes 2 weeks to exert effect → NOT for acute anxiety
Pregabalin
+presynaptic GABA release by binding voltage gated Ca channels leading to Ca influx
+GABA biosynthesis
Adverse effects: Lower dependence risk than BZs
Abrupt discontinuation → withdrawal → anxiety, nervousness, irritability
Hydroxyzine
H1 antihistamine
5-HT antagonist
Use: GAD
Adverse effects: Antihistamine, anticholinergic, antidopaminerigic →solmnolence, dry mouth, GI disturbances, blurred vision, dyskinesias
Fluoxetine
SSRI
Additional use: ADHD (adults), bulimia nervosa
active metabolite has long 1/2 life (7-9 days) so wait a bit before switching to MAOIs to prevent serotonin syndrome
Cyp inhibitor (affects TCAs and haloperidol, risperidone, codeine, beta blockers)
Fluvoxamine
SSRI
Paroxetine
SSRI Cyp inhibitor (affects TCAs and haloperidol, risperidone, codeine, beta blockers)
sertraline
SSRI